Stephan Bonnar and Josh Barnett , mixed martial arts (MMA) fighters from the UFC and PRIDE Fighting Championships , have also tested positive for the banned substance.  After the World Extreme Cagefighting show on January 20, 2006 Muay Thai turned MMA fighter Kit Cope also tested positive for boldenone.  Following the Strikeforce card on June 22, 2007 former PRIDE and UFC fighter Phil Baroni tested positive for boldenone, as well as stanozolol .  At a K-1 WGP event in Las Vegas on August 17, 2007 two fighters, Rickard Nordstrand and Zabit Samedov , both tested positive for boldenone.  Alexandre Franca Nogueira tested positive for boldenone in July 2008. 
EQ is created by chemically bonding the Boldenone hormone structure to a undecylenate ester, making the Boldenone into a raw material like syrup. The oily Boldenone Undecylenate can be mixed with sterile oil or a solvent like benzyl alcohol. This creates an oil based suspension that is then injectable directly into the muscle. EQ is versatile enough to be used for both bulking and cutting cycles. With cutting the EQ is stacked with Winstrol and Trenbolone and during bulking is stacked with testosterone and Dianabol (Enanthate or Cypionate). It is recommended that you use cycle aids during an EQ run, both N2Guard and Cardarine. Additionally, Arimidex or Aromasin, both Aromatase inhibitors, are necessary with Boldenone Undecylenate. Either, but not both Arimidex or Aromasin.
Aromatase inhibitors are the compounds that serve to reduce estradiol levels in blood by eliminating the production of estradiol through binding to and disabling the aromatase enzyme, which is responsible for the conversion (or aromatization) of androgens into estradiol. Suicidal aromatase inhibitors serve to permanently inhibit and disable the aromatase enzyme to which it is bound to. This renders the enzyme inactive forever. The body will eventually manufacture more aromatase enzymes, but the currently-bound enzymes are bound indefinitely, eliminating any risk for estrogen rebound. This is the main difference compared alongside two other major aromatase inhibitors: anastrozole and letrozole, which are non-suicidal aromatase inhibitors that are only bound to the aromatase enzyme for limited time periods. If a non-suicidal aromatase inhibitor is halted too abruptly, the circulating inhibited aromatase enzymes that have not been metabolized out of the body will then become free again, and begin aromatizing androgens into estrogens at an often rapid rate. This is not the case with Exos.